top border
top border
Featured Programs
Metastatic Breast Cancer Treatment Challenges
Ian E. Krop, MD, and Hope S. Rugo, MD, evaluate clinical trial data of anti-human epidermal growth factor receptor 2 (HER2) agents in the treatment of breast cancer. View Now

In this segment, Edith Perez, MD; Debu Tripathy, MD; Carlos L. Arteaga, MD; and Joyce O'Shaughnessy, MD, examine results from metastatic breast cancer clinical trials, ExteNET and NEfERTT. View Now
Featured Video
Dr. Esteva on the Future of Biosimilars in Breast Cancer
Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now
Gina Columbus

Gina Columbus highlights the latest news in oncology in this week's OncLive News Network.

Publication Bottom Border
Border Publication
x